Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients

被引:35
作者
Wan, Chonghua [1 ]
Tang, Xueliang
Tu, Xin M.
Feng, Changyong
Messing, Susan
Meng, Qiong
Zhang, Xiaoqing
机构
[1] Kunming Med Coll, Fac Publ Hlth, Kunming 650031, Yunnan, Peoples R China
[2] Oncol Hosp Yunnan Prov, Kunming 650031, Peoples R China
[3] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA
关键词
breast cancer; QLQ-C30 and QLQ-BR23; quality of life; psychometric properties;
D O I
10.1007/s10549-006-9443-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A Simplified Chinese version of the EORTC QLQ-BR53 was evaluated using responses from 233 patients with breast cancer in China by assessing the construct and criterion-related validity, internal consistency and test-retest reliability, and responsiveness as measured by score changes of the scales. Internal consistency reliability measured by Cronbach's coefficient alpha is greater than 0.75 for most multi-item scales except cognitive functioning (0.41) and breast symptoms (0.71). Test-retest reliability coefficients for all domains are greater than 0.80 with the exception of physical functioning (0.65), social functioning (0.75), appetite loss (0.75), diarrhea (0.72), and body image (0.72). Correlation and factor analysis among domains and items showed good construct validity for both QLQ-C30 and QLQ-BR23. Score changes over time were observed in most domains except emotional functioning, global health status/QOL, dyspnoea, constipation, diarrhea, financial difficulties, sexual functioning, sexual enjoyment, and breast symptoms. Therefore, the Simplified Chinese version of QLQ-BR53 shows reasonable validity, reliability, and responsiveness and can be used to measure QOL for Chinese patients with breast cancer.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 13 条
[1]   THE EORTC MODULAR APPROACH TO QUALITY-OF-LIFE ASSESSMENT IN ONCOLOGY [J].
AARONSON, NK ;
CULL, A ;
KAASA, S ;
SPRANGERS, MAG .
INTERNATIONAL JOURNAL OF MENTAL HEALTH, 1994, 23 (02) :75-96
[2]  
[Anonymous], 2001, CANC INCIDENCE SURVI
[3]   Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument [J].
Brady, MJ ;
Cella, DF ;
Mo, F ;
Bonomi, AE ;
Tulsky, DS ;
Lloyd, SR ;
Deasy, S ;
Cobleigh, M ;
Shiomoto, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :974-986
[4]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[5]   Quality of life of breast cancer patients in Taiwan: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23 [J].
Chie, WC ;
Chang, KJ ;
Huang, CS ;
Kuo, WH .
PSYCHO-ONCOLOGY, 2003, 12 (07) :729-735
[6]   Responsiveness of the quality of life in epilepsy inventory (QOLIE-89) in an antiepileptic drug trial [J].
Kim, S ;
Hays, RD ;
Birbeck, GL ;
Vickrey, BG .
QUALITY OF LIFE RESEARCH, 2003, 12 (02) :147-155
[7]   The responsiveness of headache impact scales scored using 'classical' and 'modern' psychometric methods: A re-analysis of three clinical trials [J].
Kosinski, M ;
Bjorner, JB ;
Ware, JE ;
Batenhorst, A ;
Cady, RK .
QUALITY OF LIFE RESEARCH, 2003, 12 (08) :903-912
[8]   The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): Translation and validation study of the Iranian version [J].
Montazeri, A ;
Harirchi, I ;
Vahdani, M ;
Khaleghi, F ;
Jarvandi, S ;
Ebrahimi, M ;
Haji-Mahmoodi, M .
QUALITY OF LIFE RESEARCH, 2000, 9 (02) :177-184
[9]   THE DEVELOPMENT OF A METHOD FOR ASSESSING THE QUALITY OF LIFE OF CANCER-PATIENTS [J].
SELBY, PJ ;
CHAPMAN, JAW ;
ETAZADIAMOLI, J ;
DALLEY, D ;
BOYD, NF .
BRITISH JOURNAL OF CANCER, 1984, 50 (01) :13-22
[10]  
SOCIETY AC, 2000, CANC FACTS FIGURES 2